Procopio Perspectives Procopio

In Part Two, John and Matt continue their discussion of the Advanced Clean Fleets Regulation, which became effective on October 1, 2023, focusing on the requirements applicable to High Priority and Federal Fleets.

Should State and Local Governments be concerned about California’s 2024 mandate to purchase zero emission fleet vehicles given that many of those vehicles do not yet exist? Join John Lormon, the leader of Procopio’s Energy and Environmental Practice Group, and Matt Abbot, an associate attorney, for the first in a series of discussions about California’s Advanced Clean Fleets Regulation.

Keeping costs in check is critical when pursuing patent protection, in particular for small and mid-sized companies. In this podcast, Procopio Partner Ernest Huang of Silicon Valley and AOMB Partner Ernest Baeten of the Netherlands discuss an innovative way in the Dutch patent system to get a peek at what the prior art is going to look like when you submit a provisional or normal patent application. The two explore how this approach can be cost-effective in the patent prosecution process, and possible implications in litigation.

A significant development in the patent world will take place on June 1, 2023, when European Union members will begin participating in a Unified Patent Court, or UPC. Originally agreed upon by most EU member states in January 2022, this new approach to handling infringement cases and revocation proceedings of European patents will now go into effect following ratification by Germany. The Unitary Patent will also be available from June 1, 2023.

The U.S. Supreme Court is considering whether an Amgen patent--which claims antibodies by functional antigen binding and does not disclose the full range of antibody sequences--is invalid for not meeting the enablement requirements of Section 112(a). Three Procopio IP Partners--experts in patent prosecution and patent litigation--discuss the background of the case, in particular how the High Court’s decision may impact the ability to obtain certain life science, chemical and pharma patents and how it may provide additional ammunition to attack such patents in patent litigation.

In this podcast, we interactively discuss about the similarities and differences in the application of the grace period in various jurisdictions, and provide examples and hypotheticals about when and the grace period can be applied, as well as situations in which it cannot be applied. We cover the timing, scope of included activities, parties covered and exceptions, as well as the procedural requirements. We also cycle through a set of fact patterns with some nuances and variations, and discuss the differences in how the grace period can be applied in each situation. Our conversation concludes with some practical considerations for applicants considering filing in the various jurisdictions in question.